BIO-SOLIFENACIN

biomed pharma🇨🇦 Health Canada

Approval Id: f71e3b68b6fdec38
Drug Approval Canada Name: BIO-SOLIFENACIN
Product Name: BIO-SOLIFENACIN
Status: Marketed
Status Date: 2022-04-13
Original Market Date: 2022-04-13
Din: 02516519
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 86:12.04
Atc Original: G04BD08 SOLIFENACIN
Atc Name: g 04 bd 08
Aig Number: 0151584001
Company Name: biomed pharma
Company Address: 1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8

SOLIFENACIN SUCCINATE

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f71e3b68b6fdec38

Type

Standard